Discovery of a significant optical chromatographic difference between spores of Bacillus anthracis and its close relative, Bacillus thuringiensis

Analytical Chemistry
S J HartRhonda Stroud

Abstract

A significant difference between two closely related Bacillus spores has been discovered using optical chromatography. This difference can be harnessed for the separation of microscopic particles using opposing laser and fluid flow forces. Particles of different size, composition, and shape experience different optical and fluid forces and come to rest at unique equilibrium positions where the two forces balance. Separations in excess of 600 mum have been observed between Bacillus anthracis Sterne strain and its genetic relative, Bacillus thuringiensis. These findings open new possibilities for detection and characterization of the biological warfare agent, B. anthracis, the causative agent of anthrax, the deadly mammalian disease. The large optical separation between these species is surprising given their close genetic relationship but may be explained by differences in their shape and exosporium morphology, which may result in differences in fluid drag force. The observation of large differences due to less common variables indicates the complex nature of the force balance in optical chromatography, which may in the future be used to separate and characterize microbiological samples. In general, the discovery of such large d...Continue Reading

References

May 1, 1989·The Journal of Applied Bacteriology·A P Phillips, J W Ezzell
Jul 15, 1997·Analytical Chemistry·T KanetaT Imasaka
Jun 1, 2000·Applied and Environmental Microbiology·E HelgasonA B Kolstø
Jun 8, 2002·Science·Alex TerrayDavid W M Marr
Jul 18, 2002·Accounts of Chemical Research·J Cooper McDonald, George M Whitesides
Dec 7, 2002·Biotechnology Progress·John OakeyDavid W M Marr
Dec 1, 1964·Journal of Bacteriology·P GERHARDT, E RIBI
Dec 4, 2003·Nature·M P MacDonaldK Dholakia
Dec 15, 1987·Applied Optics·T N BuicanJ C Martin

❮ Previous
Next ❯

Citations

Dec 18, 2013·World Journal of Microbiology & Biotechnology·Jenia A M TuftsShawn P Ryan
Apr 3, 2008·Journal of the Royal Society, Interface·Hu Zhang, Kuo-Kang Liu
Nov 26, 2010·Investigative Genetics·David L GreenbergDavid M Wagner
Jan 1, 2009·Biomicrofluidics·Alex TerraySean J Hart
Aug 31, 2010·Journal of Biomedical Optics·David James StevensonKishan Dholakia
Dec 14, 2011·Current Opinion in Biotechnology·Praveen C Ashok, Kishan Dholakia
Mar 5, 2007·Optics Express·Sean J HartTomasz A Leski
Apr 3, 2019·Physical Review. E·Ji Young MoonJoon Sang Lee
Jun 13, 2017·Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry·Manami MitsunobuTakashi Kaneta
Jan 1, 2008·Microfluidics and Nanofluidics·Hamish C Hunt, James S Wilkinson
Apr 27, 2012·Optics Express·Hamish C Hunt, James S Wilkinson
Jun 15, 2019·Scientific Reports·Xiangchao ZhuAhmet Ali Yanik
Jan 26, 2012·Optics Express·Hongxiang LeiBaojun Li
Feb 4, 2009·Optics Express·Alex TerraySean J Hart
Jan 19, 2011·Lab on a Chip·David EricksonSudeep Mandal
Jul 5, 2008·Analytical Chemistry·Sang Bok KimSang Soo Kim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.